This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Drug Conjugates
August 16-17, 2023
Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST
Menu

James Italia
VP of Commercial Development at BrickBio, USA
Speaker

Agenda Sessions

  • Antibody Drug Conjugates with Improved Therapeutic Indexes Driven by Optimal Conjugation Site

    , 13:05
    View Session

  • Panel Discussion: ADC Design and Development from the Biotech Perspective

    , 08:05
    View Session

At this event

Prev
Next
Eunju Jang
Senior Scientist
AbbVie, USA

See James at Antibody Drug Conjugates